PubRank

Jeffrey M Fowler

Author PubWeight™ 67.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 2003 8.31
2 Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup. J Clin Oncol 2009 5.37
3 Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging. Gynecol Oncol 2012 2.13
4 Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer. Gynecol Oncol 2011 1.72
5 Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol 2002 1.57
6 Bevacizumab and weekly taxane chemotherapy demonstrates activity in refractory ovarian cancer. Gynecol Oncol 2006 1.57
7 Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma. Obstet Gynecol 2007 1.49
8 Robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer. Obstet Gynecol 2008 1.47
9 Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol 2012 1.46
10 HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients. J Clin Oncol 2006 1.41
11 Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy. Gynecol Oncol 2003 1.40
12 Comprehensive surgical staging for endometrial cancer in obese patients: comparing robotics and laparotomy. Obstet Gynecol 2009 1.22
13 Minimally invasive comprehensive surgical staging for endometrial cancer: Robotics or laparoscopy? Gynecol Oncol 2009 1.20
14 Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients. Gynecol Oncol 2004 1.17
15 Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol 2005 1.10
16 Direct and buffering effects of social support among gynecologic cancer survivors. Ann Behav Med 2010 1.07
17 A detailed analysis of the learning curve: robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer. Gynecol Oncol 2009 1.05
18 Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer. Gynecol Oncol 2009 1.02
19 Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors. J Clin Oncol 2009 1.02
20 Sexual self schema as a moderator of sexual and psychological outcomes for gynecologic cancer survivors. Arch Sex Behav 2008 1.02
21 Assessment of the effects of severe obesity and lifestyle risk factors on stage of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2012 1.01
22 Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group study. Gynecol Oncol 2005 1.00
23 Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer. Int J Radiat Oncol Biol Phys 2009 1.00
24 Chylous ascites following treatment for gynecologic malignancies. Gynecol Oncol 2002 0.97
25 Improved survival with an intact DNA mismatch repair system in endometrial cancer. Obstet Gynecol 2006 0.97
26 Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centers. Gynecol Oncol 2012 0.96
27 Clinical and pathologic correlates in surgical stage II endometrial carcinoma. Obstet Gynecol 2007 0.96
28 Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer. Gynecol Oncol 2008 0.95
29 Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer. Gynecol Oncol 2010 0.91
30 Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage disease. Gynecol Oncol 2013 0.90
31 Lymphadenectomy for endometrial cancer: the controversy. Gynecol Oncol 2010 0.89
32 Reducing readmissions after robotic surgical management of endometrial cancer: a potential for improved quality care. Gynecol Oncol 2013 0.89
33 Sexual morbidity associated with poorer psychological adjustment among gynecological cancer survivors. Int J Gynecol Cancer 2010 0.89
34 Complications after double-barreled wet colostomy compared to separate urinary and fecal diversion during pelvic exenteration: time to change back? Gynecol Oncol 2012 0.87
35 Pain in the foot: calcaneal metastasis as the presenting feature of endometrial cancer. Obstet Gynecol 2002 0.87
36 Analysis of disease recurrence and survival for women with uterine malignancies undergoing robotic surgery. Gynecol Oncol 2012 0.85
37 Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer? Gynecol Oncol 2003 0.84
38 CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy. Gynecol Oncol 2008 0.82
39 Isolated groin recurrence of vulvar cancer salvaged with multimodality therapy. Gynecol Oncol 2009 0.82
40 Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy. Int J Gynecol Cancer 2015 0.82
41 Swelling among women who need education about leg lymphedema: a descriptive study of lymphedema in women undergoing surgery for endometrial cancer. Int J Gynecol Cancer 2014 0.81
42 Pre-emptive analgesia in gynecologic surgical procedures: preoperative wound infiltration with ropivacaine in patients who undergo laparotomy through a midline vertical incision. Am J Obstet Gynecol 2003 0.81
43 Documentation of Pregnancy Risk Assessment and Pregnancy Among Women Presenting for Gynecologic Oncology Consultation. Int J Gynecol Cancer 2016 0.81
44 A black raspberry extract inhibits proliferation and regulates apoptosis in cervical cancer cells. Gynecol Oncol 2011 0.81
45 Recurrent ovarian cancer: is there a role for re-treatment with bevacizumab after an initial complete response to a bevacizumab-containing regimen? Gynecol Oncol 2012 0.81
46 The impact of close surgical margins after radical hysterectomy for early-stage cervical cancer. Gynecol Oncol 2012 0.80
47 Robotic pelvic and aortic lymphadenectomy for endometrial cancer: the console surgeon's perspectives on surgical technique and directing the assistant. J Minim Invasive Gynecol 2010 0.79
48 Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer? Int J Gynecol Cancer 2013 0.78
49 Are prediction models for Lynch syndrome valid for probands with endometrial cancer? Fam Cancer 2009 0.78
50 Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol 2012 0.77
51 Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma. Gynecol Oncol 2008 0.77
52 Robotic Hysterectomy for Endometrial Cancer in Obese Patients With Comorbidities: Evaluating Postoperative Complications. Int J Gynecol Cancer 2015 0.77
53 Outpatient platinum-taxane intraperitoneal chemotherapy regimen for ovarian cancer. Int J Gynecol Cancer 2009 0.77
54 Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study. Gynecol Oncol 2002 0.77
55 Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective Cohort. Int J Gynecol Cancer 2016 0.76
56 Feasibility of interval cytoreduction following neoadjuvant chemotherapy with carboplatin, weekly paclitaxel, and bevacizumab for advanced ovarian cancer--a phase 1 study. Int J Gynecol Cancer 2014 0.76
57 Response to Dr. Carter's letter to the editor regarding "Short and long term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging". Gynecol Oncol 2012 0.75
58 Role of lymphadenectomy in the staging of endometrial cancer. Nat Rev Clin Oncol 2009 0.75
59 The Use of Transvaginal Ultrasound in Type II Endometrial Cancer. Int J Gynecol Cancer 2015 0.75
60 Ureteroileoneocystostomy: the use of an ileal segment for ureteral substitution in gynecologic oncology. Gynecol Oncol 2002 0.75
61 Hysterectomy for the treatment of gynecologic malignancy. Clin Obstet Gynecol 2014 0.75
62 We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies. Gynecol Oncol 2013 0.75